The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy

被引：3
|
作者：
Chowdhury, Simon [1 ]
Harper, Peter G. [2 ]
Choueiri, Toni K.
机构：
[1] Guys Hosp, Dept Med Oncol, London SE1 9RT, England
[2] Guys & St Thomas Hosp, Natl Hlth Serv Trust, London SE1 9RT, England
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 12期
关键词：
D O I：
10.1038/ncponc1256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：698 / 699
页数：2
相关论文
共 50 条
  • [41] The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma
    Umbreit, Eric C.
    McIntosh, Andrew G.
    Suk-Ouichai, Chalairat
    Karam, Jose A.
    Wood, Christopher G.
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (01) : 13 - 16
  • [42] Commentary on the role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Schulz, Gerald
    AKTUELLE UROLOGIE, 2023, 54 (03) : 180 - 181
  • [43] The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Graham, Jeffrey
    Bhindi, Bimal
    Heng, Daniel Y. C.
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 507 - 512
  • [44] Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Van Praet, Charles
    Slots, Charlotte
    Vasdev, Nikhil
    Roney, Sylvie
    Fonteyne, Valerie
    Andras, Lulia
    Albersen, Maarten
    De Meerleer, Gert
    Bex, Axel
    Decaestecker, Karel
    TURKISH JOURNAL OF UROLOGY, 2021, 47 : S79 - S84
  • [45] The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma
    Wood, CG
    UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (03) : 581 - +
  • [46] Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature
    Mazzaschi, Giulia
    Quaini, Federico
    Bersanelli, Melissa
    Buti, Sebastiano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [47] Cytoreductive nephrectomy plus targeted therapy versus targeted therapy alone in metastatic renal cell carcinoma: a retrospective cohort study
    Choi, S. W.
    Fok, C. Y.
    Teoh, J. Y.
    Hou, S. M.
    Ng, C. F.
    BJU INTERNATIONAL, 2017, 119 : 11 - 12
  • [48] The Impact of Targeted Therapy on Management of Metastatic Renal Cell Carcinoma: Trends in Systemic Therapy and Cytoreductive Nephrectomy Utilization
    Psutka, Sarah P.
    Kim, Simon P.
    Gross, Cary P.
    Van Houten, Holly
    Thompson, R. Houston
    Abouassaly, Robert
    Weight, Christopher
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Shah, Nilay D.
    UROLOGY, 2015, 85 (02) : 442 - 450
  • [49] Role of cytoreductive nephrectomy (CRN) for metastatic renal cell carcinoma (mRCC) in the era of targeted therapy (TKI): experience from three hong kong tertiary centres
    Chan, K. W.
    Tsu, H. L.
    Ma, W. K.
    Kan, C. F.
    Leung, A. K. C.
    Ip, C. H.
    Kan, W. M.
    Cheung, F. K.
    Chan, W. H.
    Au, W. H.
    Yiu, M. K.
    BJU INTERNATIONAL, 2014, 113 : 2 - 2
  • [50] Role of molecular markers in nephrectomy specimen as prognosticators for patients with metastatic renal cell carcinoma in the era of targeted therapy
    You, D.
    Cho, Y. M.
    Ahn, J. H.
    Lee, D. H.
    Lee, J. L.
    Hong, J. H.
    Kim, C. S.
    Ahn, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E313 - E313
12345